Proportion of the target population who received 3 doses of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand): Proportion of the target population who received 3 doses of was 94.0% in 2024. ▬ Flat
Proportion of the target population who received 3 doses of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), 2000–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) recorded 94.0% for proportion of the target population who received 3 doses of in 2024.
Compared with earlier readings it is up 1.1% over ten years.
Over the whole period, proportion of the target population who received 3 doses of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) peaked at 96.0% in 2004 and was at its lowest, 93.0%, in 2000.
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 2nd of 37 groups on this measure, in the top 10%.
Proportion of the target population who received 3 doses of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 93.0% | — |
| 2001 | 95.0% | +2.2% |
| 2002 | 95.0% | +0.0% |
| 2003 | 95.0% | +0.0% |
| 2004 | 96.0% | +1.1% |
| 2005 | 96.0% | +0.0% |
| 2006 | 96.0% | +0.0% |
| 2007 | 96.0% | +0.0% |
| 2008 | 96.0% | +0.0% |
| 2009 | 95.0% | -1.0% |
| 2010 | 94.0% | -1.1% |
| 2011 | 94.0% | +0.0% |
| 2012 | 95.0% | +1.1% |
| 2013 | 94.0% | -1.1% |
| 2014 | 93.0% | -1.1% |
| 2015 | 93.0% | +0.0% |
| 2016 | 93.0% | +0.0% |
| 2017 | 93.0% | +0.0% |
| 2018 | 94.0% | +1.1% |
| 2019 | 94.0% | +0.0% |
| 2020 | 94.0% | +0.0% |
| 2021 | 94.0% | +0.0% |
| 2022 | 94.0% | +0.0% |
| 2023 | 94.0% | +0.0% |
| 2024 | 94.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 95.3% | 93.0% | 96.0% | 10 |
| 2010s | 93.7% | 93.0% | 95.0% | 10 |
| 2020s | 94.0% | 94.0% | 94.0% | 5 |
Countries ranked near Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
- 1 Antigua and Barbuda 99.0% compare
- 1 Brunei Darussalam 99.0% compare
- 1 Costa Rica 99.0% compare
- 1 Cuba 99.0% compare
- 1 Democratic People's Republic of Korea 99.0% compare
- 1 Hungary 99.0% compare
- 1 Jamaica 99.0% compare
- 1 Japan 99.0% compare
- 1 Kuwait 99.0% compare
- 1 Luxembourg 99.0% compare
- 1 Maldives 99.0% compare
- 1 Monaco 99.0% compare
- 1 Nauru 99.0% compare
- 1 Niue 99.0% compare
- 1 Oman 99.0% compare
- 1 Portugal 99.0% compare
- 1 Saint Lucia 99.0% compare
- 1 Saint Vincent and the Grenadines 99.0% compare
- 1 Tonga 99.0% compare
- 1 Türkiye 99.0% compare
- 1 Brunei 99.0% compare
- 1 Turkey 99.0% compare
More infrastructure data for Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
- Developing countries’ and least developed countries’ share of global 55.7% (2024)
- Developing countries’ and least developed countries’ share of global 51.7% (2024)
- Developing countries’ and least developed countries’ share of global 64.2% (2024)
- Developing countries’ and least developed countries’ share of global 68.5% (2024)
- Total official flows for infrastructure, by recipient countries 6,728 (2024)
- Proportion of the target population who received 91.0% (2024)
- Container port traffic, maritime transport 221.66 million (2024)
- Proportion of the target population who received a 3rd dose of 84.0% (2024)
- Proportion of tariff lines applied to imports with zero-tariff 56.8% (2024)
- Data Infrastructure performance index (Statistical Performance) 83.33 (2024)
Frequently asked questions
- What is proportion of the target population who received 3 doses of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- Proportion of the target population who received 3 doses of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) was 94.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest proportion of the target population who received 3 doses of recorded in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- The highest recorded value was 96.0% in 2004.
- What is the lowest proportion of the target population who received 3 doses of recorded in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- The lowest recorded value was 93.0% in 2000.
- How does Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank for proportion of the target population who received 3 doses of?
- Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 2nd out of 37 groups with data for 2024.
- Is proportion of the target population who received 3 doses of rising or falling in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is flat.
- Where does this Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under UN SDG Global Database (open, attribution requested).